More on LABT
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.65 |
|
|||
| Open | $3.53 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $4.13 | ||||
| Day Low | $3.42 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 43,421 | ||||
- Form SCHEDULE 13G Lakewood-Amedex Biothera Filed by: HPW Investments Holding Ltd.
- Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
- Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
- Form 424B3 Lakewood-Amedex Biothera
- Form 424B3 Lakewood-Amedex Biothera
- Lakewood-Amedex receives Australian patent for antimicrobial compounds
- Lakewood-Amedex Biotherapeutics Secures Composition of Matter Patent Protecting New Bisphosphocin® Compounds Being Developed for High-Need Antimicrobial Infections
- Form 8-K Lakewood-Amedex Biothera For: Jun 15
- Lakewood-Amedex Biotherapeutics to Present at Life Sciences Virtual Investor Forum
- Lakewood-Amedex secures patents in Australia and New Zealand for Nu-3
Entities mentioned with LABT
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- S1 | View Related Stories »
- Show More...
